Correlation Between Trinity Bio and Regeneron Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trinity Bio and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trinity Bio and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trinity Bio ADR and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Trinity Bio and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trinity Bio with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trinity Bio and Regeneron Pharmaceuticals.

Diversification Opportunities for Trinity Bio and Regeneron Pharmaceuticals

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Trinity and Regeneron is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Trinity Bio ADR and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Trinity Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trinity Bio ADR are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Trinity Bio i.e., Trinity Bio and Regeneron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Trinity Bio and Regeneron Pharmaceuticals

Given the investment horizon of 90 days Trinity Bio ADR is expected to under-perform the Regeneron Pharmaceuticals. In addition to that, Trinity Bio is 2.85 times more volatile than Regeneron Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest  64,123  in Regeneron Pharmaceuticals on April 5, 2022 and sell it today you would lose (4,583)  from holding Regeneron Pharmaceuticals or give up 7.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Trinity Bio ADR  vs.  Regeneron Pharmaceuticals

 Performance (%) 
      Timeline 
Trinity Bio ADR 
Trinity Performance
8 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Trinity Bio ADR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady forward indicators, Trinity Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Structure and Payout Changes

Last Split Factor
1:4
Dividend Date
2015-07-01
Ex Dividend Date
2015-06-05
Last Split Date
2005-06-02

Trinity Price Channel

Regeneron Pharmaceuticals 
Regeneron Performance
0 of 100
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in August 2022. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Regeneron Price Channel

Trinity Bio and Regeneron Pharmaceuticals Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Trinity Bio and Regeneron Pharmaceuticals

The main advantage of trading using opposite Trinity Bio and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trinity Bio position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.
The idea behind Trinity Bio ADR and Regeneron Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go